Clindamycine Kela 200 mg Tablet
Clindamycine Kela 200 mg Tablet
Authorised
- Clindamycin hydrochloride
Product identification
Medicine name:
Clindamycine Kela 200 mg Tablet
Clindamycine Kela 200 mg Comprimé
Clindamycine Kela 200 mg Tablette
Active substance:
- Clindamycin hydrochloride
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin hydrochloride226.70/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Clindamycine Kela 200 mg Tablet Box with 8 blisters with 10 tablets
- Clindamycine Kela 200 mg Tablet Box with 2 blisters with 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed Consent application (Article 21 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V303572
Date of authorisation status change:
Informed consent reference:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
